Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP3 | O14638 | 2/20 | 0.30 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24696441 | 0.75 | ENPP3 (0.35) | ENPP3ENPP1 | |
| SCHEMBL25824617 | 0.73 | LOXL2 (0.36) | — | |
| SCHEMBL31426304 | 0.72 | LOXL2 (0.33) | — | |
| SCHEMBL31534803 | 0.71 | LOXL2 (0.32) | — | |
| SCHEMBL31566387 | 0.69 | ENPP3 (0.30) | ENPP3ENPP1 | |
| SCHEMBL2094794 | 0.68 | ALDH1A1 (0.39) | — | |
| SCHEMBL2094327 | 0.68 | LOXL2 (0.33) | — | |
| SCHEMBL29016986 | 0.68 | MAOB (0.47) | — | |
| SCHEMBL31495824 | 0.67 | LOXL2 (0.34) | — | |
| SCHEMBL28990300 | 0.67 | LOXL2 (0.36) | ENPP3ENPP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085725-A1 | METHODS FOR TREATING A P53-ASSOCIATED CANCER | SCORPION THERAPEUTICS, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| US-20250120961-A1 | P53 MODULATORS | NESTED THERAPEUTICS INC (US) | 2025-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250120961-A1 | P53 MODULATORS | TP53, TP53BP1, MDM2 | ENPP3 1206/4885ENPP1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.